Sulfonylurea managementgroupChange in A1C (%) Incidence of hypoglycemia (%) Placebo 5 /H9262g exenatide 10/H9262g exenatide Placebo 5 /H9262g exenatide 10 /H9262g exenatide MAX /H110010.2/H110060.1 /H110020.7/H110060.1; P/H110210.0001* /H110020.9/H110060.1; P/H110210.0001* 15% 22% 35% MIN /H110010.3/H110060.1 /H110020.4/H110060.1; P/H110210.0001* /H110020.6/H110060.1; P/H110210.0001* 10% 16% 21% Data are means /H11006SE, unless otherwise noted. *A1C change comparison for exenatide treatment versus placebo.Exenatide and glycemic control 1090 DIABETES CARE,VOLUME 28, NUMBER 5, M AY2005